- Home
- ACIU vs COOK Comparison
ACIU vs COOK Comparison
Compare ACIU & COOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- COOK
- Stock Information
- Founded
- ACIU 2003
- COOK 1985
- Country
- ACIU Switzerland
- COOK United States
- Employees
- ACIU N/A
- COOK N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- COOK Wholesale Distributors
- Sector
- ACIU Health Care
- COOK Consumer Discretionary
- Exchange
- ACIU Nasdaq
- COOK Nasdaq
- Market Cap
- ACIU 247.4M
- COOK 237.8M
- IPO Year
- ACIU 2016
- COOK 2021
- Fundamental
- Price
- ACIU $1.77
- COOK $1.52
- Analyst Decision
- ACIU Strong Buy
- COOK Hold
- Analyst Count
- ACIU 2
- COOK 6
- Target Price
- ACIU $12.00
- COOK $2.83
- AVG Volume (30 Days)
- ACIU 185.3K
- COOK 210.8K
- Earning Date
- ACIU 05-12-2025
- COOK 05-07-2025
- Dividend Yield
- ACIU N/A
- COOK N/A
- EPS Growth
- ACIU N/A
- COOK N/A
- EPS
- ACIU N/A
- COOK N/A
- Revenue
- ACIU $30,136,397.00
- COOK $604,072,000.00
- Revenue This Year
- ACIU N/A
- COOK $2.02
- Revenue Next Year
- ACIU $680.74
- COOK $5.30
- P/E Ratio
- ACIU N/A
- COOK N/A
- Revenue Growth
- ACIU 84.51
- COOK N/A
- 52 Week Low
- ACIU $1.77
- COOK $1.50
- 52 Week High
- ACIU $4.98
- COOK $3.97
- Technical
- Relative Strength Index (RSI)
- ACIU 25.49
- COOK 22.68
- Support Level
- ACIU $1.77
- COOK $1.70
- Resistance Level
- ACIU $2.05
- COOK $1.89
- Average True Range (ATR)
- ACIU 0.12
- COOK 0.11
- MACD
- ACIU -0.02
- COOK 0.00
- Stochastic Oscillator
- ACIU 0.00
- COOK 3.85
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About COOK Traeger Inc.
Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.